• Corpus ID: 78888724

Review on: Adverse Drug Reactions of Chemotherapy Drugs

  title={Review on: Adverse Drug Reactions of Chemotherapy Drugs},
  author={M. Mounika},
  journal={Research and Reviews: Journal of Pharmacology and Toxicological Studies},
  • M. Mounika
  • Published 1 September 2016
  • Medicine, Biology
  • Research and Reviews: Journal of Pharmacology and Toxicological Studies
Adverse drug reactions responses are because of the use of anticancer medications are an overall issue and can't be neglected. Adverse drug reactions can range from nausea, vomiting or any other mild reaction to severe myelosuppression. ADRs are most basic purposes behind morbidity and mortality and expansion the monetary burden on patient and society. Via cautious ADR checking, their frequency can be diminished 
1 Citations

Tables from this paper


Most ADR’s are preventable with effective ADR monitoring, and there is an immediate need to create awareness among health care professionals regarding the importance of the pharmacovigilance system.



Monitoring of Suspected Adverse Drug Reactions in Oncology Unit of an Urban Multispeciality Teaching Hospital

Monitoring suspected ADRs in the oncology unit of a tertiary care teaching hospital to understand the strengths and limitations of cross-sectional observational pharmacovigilance activity for anticancer drugs and the inability to identify ADRs that require serial clinical or laboratory monitoring and the lack of scope for picking up chronic or delayed ADRs.

Adjunctive Corticosteroid to Counteract Adverse Drug Reactions from First-Line Antituberculous Drugs

Patients receiving prednisolone to counteract ADRs, despite desensitization therapy, display modest benefits in anti-TB treatment completion.

The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?

ADRs are common in hospitalised oncology patients and are predictable and at least probably preventable in many instances, and improved use of preventative measures has the potential to contribute to reducing the incidence and severity of ADRs.

Pharmacogenomics-Guided Approaches to Avoiding Adverse Drug Reactions

As affordable and reliable genetic testing tools become available to physicians, pharmacogenomics looks promising to facilitate individualization of drug therapy and as a result, this will maximize the therapeutic efficacy of drugs in patients while minimizing the occurrence of ADRs.

Extended Arm Necrosis by Chemotherapy Drugs Extravasation

Passage in extravascular areas of chemotherapy drugs is a relatively less frequent incident but may lead to injury up to the extensive tissue necrosis that can worsen the patient's prognosis and alter his functional life comfort.

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

The objective was to quantify the ADR‐related economic burden (direct costs) of hospitalizations in internal medicine wards in Germany.

Point-of-Care for Therapeutic Drug Monitoring of Antineoplastic Drugs

This practice allows for rapid medical intervention in case of toxicity-related issues and/or adjustment of dosage to better fit the therapeutic demand.

Recognizing, reporting, and reducing adverse drug reactions.

Reducing the number of ADRs can be accomplished by systems changes made at an individual and national level and by expanding the role of the arm of the Food and Drug Administration responsible for postmarketing surveillance.

The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs.

  • S. NiraulaB. Šeruga E. Amir
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2012
New anticancer agents that lead to improvements in time-to-event end points also increase morbidity and treatment-related mortality.

Herbal Anti-Cancer Drugs: A Better Way to Cure the Disease